https://www.selleckchem.com/pr....oducts/cabotegravir-
xcellent response patients and patients with indeterminate response and s-Tg ≤ 2ng/ml could be managed without RAI therapy. The current study suggested that the response to therapy assessment immediately applied postoperatively could help avoid unnecessary RAI therapy among DTC patients with capsular invasion and/or LNM. Moreover, excellent response patients and patients with indeterminate response and s-Tg ≤ 2ng/ml could be managed without RAI therapy. Esophageal cancer is currently a worldwide health problem. Es
Like
Comment
Share
